Raducanu Targets Strasbourg Return as Two-Month Absence Nears End

Emma Raducanu will attempt to return to the WTA Tour at the Internationaux de Strasbourg, scheduled to begin on 19 May 2026. The British player confirmed her targeted comeback on 6 May 2026, following a withdrawal from the Italian Open in Rome where she cited a post-viral illness that has kept her from competing for two months.

The announcement marks the latest chapter in a career that has been repeatedly interrupted by injury and illness since her stunning US Open triumph in 2021. Raducanu, now 23, has struggled to build sustained momentum on tour, with this latest absence representing one of the longest gaps in her professional career.

The Rome Withdrawal

Raducanu withdrew from the Italian Open before her first-round match, according to reports published on 5 May 2026 by BBC Sport and Sky Sports. The withdrawal came after she had been listed to compete in Rome, suggesting the decision to pull out was made only after she arrived and assessed her fitness. A post-viral illness was cited as the reason, with team sources indicating the condition had prevented her from training at full intensity in the weeks leading up to the tournament.

The Italian Open represented what had seemed like a logical return point after earlier target dates passed without Raducanu taking the court. Her last competitive appearance on the WTA Tour came approximately two months prior, making this the longest single absence of her professional career.

A Comeback Measured in Caution

In a statement carried by BBC Sport on 5 May 2026, Raducanu acknowledged she was "in a better place" than she had been but stopped short of declaring herself fully recovered. "Not 100%" was her own assessment, a notable degree of candour from a player who has often been guarded about physical setbacks. The phrasing suggests a managed return rather than a triumphant one — one where fitness is being rebuilt through competition rather than confirmed before it begins.

That caution is understandable. Raducanu has endured multiple surgeries and medical procedures since 2022, including operations on both wrists and an appendectomy. Each return has required patience, and each interruption has raised fresh questions about her durability at the elite level. The pattern has become a recurring feature of her narrative: a promising run, an injury, a withdrawal, a gradual rebuild.

Strasbourg, a WTA 250 tournament held on clay, offers a lower-pressure environment than the larger events. The draw is smaller, the expectations less intense, and the surface traditionally favours players willing to construct points patiently — a style that suits Raducanu's counterpunching game when she is moving well.

What Strasbourg Offers and What It Does Not

A successful return in Alsace would answer some immediate questions. Is she healthy enough to compete at tour level? Can she string together matches without a physical breakdown? Has the time away sharpened her focus or dulled her edge? But the deeper questions — about Raducanu's long-term trajectory, her ability to sustain a top-50 presence, her psychological relationship with competitive tennis — will not be resolved in a single tournament's results.

The broader context matters here. The WTA Tour in 2026 remains fiercely competitive at every level. Players who were teenagers when Raducanu announced herself now occupy different positions in the rankings. The sport has not waited. A two-month absence in a player's mid-twenties is not catastrophic, but it is not neutral either.

What Strasbourg does offer is a starting point. If Raducanu can play three or four matches without recurrence of the illness that kept her out of Rome, she will have data — real competitive data — on what her body can handle. That information is more valuable than any ranking projection.

The Stakes Beyond the Clay

The French Open begins on 25 May 2026, less than a week after the Strasbourg final. Whether Raducanu attempts to play both events or consolidates her comeback in one tournament will depend on how the next two weeks unfold. Her team will likely prioritise getting her healthy and competitive over building match fitness through a gruelling clay-court sequence.

There is also the question of ranking. Raducanu entered 2026 outside the top 100, a function of limited playing time and early exits more than a collapse in form. A deep run in Strasbourg would begin chipping away at that deficit, but clay is not her strongest surface and the draw will not be kind.

The broader pattern in her career suggests that measured, patient returns have served her better than rushed ones. The surgeries that followed her 2022 wrist injuries required months of rehabilitation before she could train normally. Attempting to accelerate that timeline has, more than once, led to setbacks.

Whether Strasbourg marks a genuine restart or another false dawn will become clear in the coming weeks. What is certain is that the window for establishing herself as a consistent tour-level presence is not infinite. The 2026 season is nearly one-third complete. Raducanu will need to build momentum quickly if she is to avoid spending another year in the margins of the game she once illuminated.

This publication's coverage of Raducanu's comeback attempt focused on the specific timeline and medical context provided by BBC Sport and Sky Sports, rather than on broader narrative framings about her career trajectory. Wire reports on the Italian Open withdrawal were cited directly; characterisations of her long-term prospects reflect available evidence rather than speculation.